Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines

被引:0
|
作者
Sevilay Batıbay
Rezan Koçak Ulucaköy
Zafer Günendi
Işıl Fidan
Gülendam Bozdayı
Feride Nur Göğüş
机构
[1] Gazi University Hospital,Division of Rheumatology, Department of Physical Medicine and Rehabilitation
[2] Ministry of Health Ankara City Hospital,Department of Internal Medicine, Division of Rheumatology
[3] Gazi University Hospital,Medical Microbiology
来源
Inflammopharmacology | 2022年 / 30卷
关键词
Covid-19; SARS-CoV-2; Vaccine; CoronaVac; BNT162b2; Rheumatology; Inflammatory rheumatic disease;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2089 / 2096
页数:7
相关论文
共 50 条
  • [31] CoronaVac, BNT162b2 and heterologous COVID-19 vaccine and ventricular assist device: Correspondence
    Kleebayoon, Amnuay
    Wiwanitkit, Viroj
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2023, 46 (05): : 255 - 255
  • [32] Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study
    Suah, Jing Lian
    Husin, Masliyana
    Tok, Peter Seah Keng
    Tng, Boon Hwa
    Thevananthan, Thevesh
    Low, Ee Vien
    Appannan, Maheshwara Rao
    Zin, Faizah Muhamad
    Zin, Shahanizan Mohd
    Yahaya, Hazlina
    Peariasamy, Kalaiarasu M.
    Sivasampu, Sheamini
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 119 : 69 - 76
  • [33] Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
    Jaime S. Rosa Duque
    Xiwei Wang
    Daniel Leung
    Samuel M. S. Cheng
    Carolyn A. Cohen
    Xiaofeng Mu
    Asmaa Hachim
    Yanmei Zhang
    Sau Man Chan
    Sara Chaothai
    Kelvin K. H. Kwan
    Karl C. K. Chan
    John K. C. Li
    Leo L. H. Luk
    Leo C. H. Tsang
    Wilfred H. S. Wong
    Cheuk Hei Cheang
    Timothy K. Hung
    Jennifer H. Y. Lam
    Gilbert T. Chua
    Winnie W. Y. Tso
    Patrick Ip
    Masashi Mori
    Niloufar Kavian
    Wing Hang Leung
    Sophie Valkenburg
    Malik Peiris
    Wenwei Tu
    Yu Lung Lau
    Nature Communications, 13
  • [34] BNT162b2 Covid-19 Vaccine in Adolescents
    Lin, Chen-Hsing
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (14): : 1342 - 1343
  • [35] Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel Diseases
    Edelman-Klapper, Hadar
    Rabinowitz, Keren Masha
    Zittan, Eran
    Shitrit, Ariella Bar-Gil
    Goren, Idan
    Avni-Biron, Irit
    Ollech, Jacob E.
    Lichtenstein, Lev
    Banai-Eran, Hagar
    Yanai, Henit
    Snir, Yifat
    Pauker, Maor H.
    Friedenberg, Adi
    Levy-Barda, Adva
    Broitman, Yelena
    Ben Zvi, Haim
    Perets, Tsachi-Tsadok
    Eliakim, Rami
    Barkan, Revital
    Goren, Sophy
    Cohen, Dani
    Dotan, Iris
    VACCINES, 2023, 11 (07)
  • [36] Serologic response and safety after third dose of the COVID-19 BNT162b2 vaccine in patients with Inflammatory Bowel Diseases
    Edelman-Klapper, H.
    Rabinowitz, K. M.
    Zittan, E.
    Shitrit, A. Bar-Gil
    Goren, I.
    Avni-Biron, I.
    Ollech, J. E.
    Lichtenstein, L.
    Banai-Eran, H.
    Yanai, H.
    Snir, Y.
    Pauker, M. H.
    Friedenberg, A.
    Levy-Barda, A.
    Segal, A.
    Broitman, Y.
    Maoz, E.
    Ovadia, B.
    Golan, M. Aharoni
    Shachar, E.
    Ben-Horin, S.
    Mor, M.
    Ben Zvi, H.
    Perets, T. T.
    Eliakim, R.
    Barkan, R.
    Navon, M.
    Gal-Tanamy, M.
    Freund, N. T.
    Goren, S.
    Cohen, D.
    Dotan, I.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 772 - 773
  • [37] Safety of BNT162b2 or CoronaVac COVID-19 vaccines in patients with heart failure: A self-controlled case series study
    Ye, Xuxiao
    Huang, Caige
    Wei, Yue
    Li, Silvia T. H.
    Yan, Vincent K. C.
    Yiu, Kai -Hang
    Tse, Hung-Fat
    Ma, Tiantian
    Qin, Xiwen
    Chui, Celine S. L.
    Lai, Francisco T. T.
    Li, Xue
    Wan, Eric Y. F.
    Wong, Carlos K. H.
    Wong, Ian C. K.
    Chan, Esther W.
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2023, 30
  • [39] Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study
    Diamantopoulos, Panagiotis T.
    Stafylidis, Christos
    Vlachopoulou, Dimitra
    Kontandreopoulou, Christina-Nefeli
    Giannakopoulou, Nefeli
    Vardaka, Maria
    Mpouhla, Anthi
    Mastrogianni, Elpida
    Variami, Eleni
    Galanopoulos, Athanasios
    Pappa, Vasiliki
    Psichogiou, Mina
    Hatzakis, Angelos
    Viniou, Nora-Athina
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [40] Effectiveness of the BNT162b2 mRNA COVID-19 vaccine among adolescents with juvenile-onset inflammatory rheumatic diseases
    Ziv, Amit
    Heshin-Bekenstein, Merav
    Haviv, Ruby
    Kivity, Shaye
    Netzer, Doron
    Yaron, Shlomit
    Schur, Yoav
    Egert, Tsipi
    Egert, Yona
    Sela, Yaron
    Hashkes, Philip J.
    Uziel, Yosef
    RHEUMATOLOGY, 2023, 62 (SI2) : SI145 - SI151